Rui Kishimoto

924 total citations
7 papers, 56 citations indexed

About

Rui Kishimoto is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Rui Kishimoto has authored 7 papers receiving a total of 56 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Rui Kishimoto's work include Genetics and Neurodevelopmental Disorders (2 papers), Epigenetics and DNA Methylation (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Rui Kishimoto is often cited by papers focused on Genetics and Neurodevelopmental Disorders (2 papers), Epigenetics and DNA Methylation (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Rui Kishimoto collaborates with scholars based in Japan, Germany and United States. Rui Kishimoto's co-authors include Nobuoki Kohno, Haruya Ohno, Masayasu Yoneda, Kazuhiro Kobuke, Kenji Oki, Yusuke Nakatsu, Tomoichiro Asano, Hirofumi Okubo, Celso E. Gómez-Sánchez and Xiaoxi Liu and has published in prestigious journals such as PLoS ONE, Human Molecular Genetics and Medicine.

In The Last Decade

Rui Kishimoto

7 papers receiving 56 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rui Kishimoto Japan	4	26	23	22	15	8	7	56
Héctor Eliud Arriaga-Cázares Mexico	3	22 0.8×	16 0.7×	12 0.5×	12 0.8×	10 1.3×	8	49
Anna Kirstine Ringgaard Denmark	3	68 2.6×	39 1.7×	28 1.3×	27 1.8×	5 0.6×	4	101
Nicolás Gómez-Banoy United States	6	14 0.5×	13 0.6×	16 0.7×	11 0.7×	12 1.5×	10	60
C. Guiducci United States	2	21 0.8×	10 0.4×	21 1.0×	13 0.9×	4 0.5×	2	38
Fabiola Turrini Italy	3	35 1.3×	20 0.9×	43 2.0×	37 2.5×	13 1.6×	3	81
Ирина Владимировна Кононенко Russia	5	16 0.6×	43 1.9×	26 1.2×	41 2.7×	11 1.4×	32	91
Divya Sri Priyanka Tallapragada India	5	37 1.4×	29 1.3×	26 1.2×	44 2.9×	12 1.5×	6	104
Jun Hosoe Japan	4	31 1.2×	30 1.3×	46 2.1×	34 2.3×	8 1.0×	7	93
G Blondin France	5	20 0.8×	27 1.2×	46 2.1×	37 2.5×	2 0.3×	11	109
Harikrishnan Kaipananickal Australia	5	14 0.5×	12 0.5×	36 1.6×	18 1.2×	7 0.9×	6	60

Countries citing papers authored by Rui Kishimoto

Since Specialization

Citations

This map shows the geographic impact of Rui Kishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Kishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Kishimoto more than expected).

Fields of papers citing papers by Rui Kishimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Kishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Kishimoto. The network helps show where Rui Kishimoto may publish in the future.

Co-authorship network of co-authors of Rui Kishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Kishimoto. A scholar is included among the top collaborators of Rui Kishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Kishimoto. Rui Kishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Sawano, Fumio, Nozomu Kamei, Kyoko Kobuke, et al.. (2021). Comprehensive efficacy of ipragliflozin on various conditioned type 2 diabetes compared with dipeptidyl peptidase-4 inhibitors and with both agents, based on a real-world multicenter trial. Diabetology International. 12(4). 364–378. 2 indexed citations

2.

Kishimoto, Rui, Kenji Oki, Masayasu Yoneda, et al.. (2016). Gonadotropin-Releasing Hormone Stimulate Aldosterone Production in a Subset of Aldosterone-Producing Adenoma. Medicine. 95(20). e3659–e3659. 19 indexed citations

3.

Nakanishi, Shuhei, et al.. (2016). Effects of microvascular complications on structural changes in visceral and subcutaneous adiposity among type 2 diabetes patients. Obesity Medicine. 1. 1–5. 1 indexed citations

4.

Yoneda, Masayasu, Hirofumi Okubo, Haruya Ohno, et al.. (2015). Distinct Time Course of the Decrease in Hepatic AMP-Activated Protein Kinase and Akt Phosphorylation in Mice Fed a High Fat Diet. PLoS ONE. 10(8). e0135554–e0135554. 17 indexed citations

5.

Kishimoto, Rui, Kota Tamada, Xiaoxi Liu, et al.. (2015). Model mice for 15q11–13 duplication syndrome exhibit late-onset obesity and altered lipid metabolism. Human Molecular Genetics. 24(16). 4559–4572. 11 indexed citations

6.

Liu, Xiaoxi, Kota Tamada, Rui Kishimoto, et al.. (2015). Transcriptome profiling of white adipose tissue in a mouse model for 15q duplication syndrome. Genomics Data. 5. 394–396. 5 indexed citations

7.

Oki, Kenji, Masayasu Yoneda, Koji Arihiro, et al.. (2015). A Patient with an Extra-adrenal Pheochromocytoma and Germ-line <i>SDHB</i> Mutation Accompanied by an Atypical Meningioma. Internal Medicine. 54(18). 2355–2360. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact